Institute for Clinical & Economic Review Issues Evidence Report Entitled 'Oral and Monoclonal Antibody Treatments for Relapsing Forms of Multiple Sclerosis'

Press/Media: Expert Comment

PeriodJan 2 2023

Media coverage

1

Media coverage